Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect

J Biol Chem. 2009 May 22;284(21):14558-71. doi: 10.1074/jbc.M900185200. Epub 2009 Mar 17.

Abstract

The G protein-coupled lysophosphatidic acid 2 (LPA(2)) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA(2). LPA(2) differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA(2) responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA(2)-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA(2). Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA(2)-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA(2)-mediated full activation of antiapoptotic signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATPases Associated with Diverse Cellular Activities
  • Adaptor Proteins, Signal Transducing / metabolism
  • Amino Acid Motifs
  • Amino Acid Sequence
  • Animals
  • Apoptosis* / drug effects
  • Calcium Signaling / drug effects
  • Cell Line, Tumor
  • Cytoprotection / drug effects
  • Doxorubicin / pharmacology
  • Female
  • GTP-Binding Proteins / metabolism
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • LIM Domain Proteins
  • Lipoylation / drug effects
  • Lysophospholipids / pharmacology
  • Mice
  • Molecular Sequence Data
  • Mutation / genetics
  • Ovarian Neoplasms / pathology
  • Phosphoproteins / metabolism
  • Proteasome Endopeptidase Complex
  • Protein Binding / drug effects
  • Receptors, Lysophosphatidic Acid / chemistry
  • Receptors, Lysophosphatidic Acid / metabolism*
  • Sodium-Hydrogen Exchangers / metabolism
  • Transcription Factors / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Lysophospholipids
  • PSMC5 protein, human
  • Phosphoproteins
  • Receptors, Lysophosphatidic Acid
  • Sodium-Hydrogen Exchangers
  • Transcription Factors
  • sodium-hydrogen exchanger regulatory factor
  • Doxorubicin
  • Proteasome Endopeptidase Complex
  • GTP-Binding Proteins
  • ATPases Associated with Diverse Cellular Activities
  • lysophosphatidic acid